Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience-Reference-Cited by-同舟云学术

Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

Published:2021-02-26 Issue:1 Volume:51 Page:297-308
ISSN:1303-6165
Container-title:TURKISH JOURNAL OF MEDICAL SCIENCES
language:
Short-container-title:Turk J Med Sci

Author:

BİLGİN Emre^ORCID,CEYLAN Furkan^ORCID,DURAN Emine^ORCID,FARİSOĞULLARI Bayram^ORCID,BÖLEK Ertuğrul Çağrı^ORCID,YARDIMCI Gözde Kübra^ORCID,KILIÇ Levent^ORCID,AKDOĞAN Ali^ORCID,KARADAĞ Ömer^ORCID,BİLGEN Şule Apraş^ORCID,KİRAZ Sedat^ORCID,ERTENLİ Ali İhsan^ORCID,KALYONCU Umut^ORCID

Publisher

The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM)

Subject

General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients;Wiener klinische Wochenschrift;2024-09-11

2. A hierarchical cluster analysis for clinical profiling of tofacitinib treatment response in patients with rheumatoid arthritis;Clinical Rheumatology;2024-06-26

3. Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention;Open Access Rheumatology: Research and Reviews;2024-06

4. Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients;Current Research in Pharmacology and Drug Discovery;2024

5. Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib;JCR: Journal of Clinical Rheumatology;2023-09-19